Roche Diagnostics has announced the global launch of enhanced software (Version 7.0) for its flagship cobas b 221 blood gas analyser system. The cobas b 221 is a desktop device designed for critical care and provides blood gas analysis, measurement of the most important electrolytes, and glucose, lactate, urea, bilirubin and haemoglobin derivatives.
Launch Diagnostics is one of the major independent distributors in the U.K, providing high quality diagnostic reagents and instrumentation from world leading manufacturer’s to the Health Services of the United Kingdom, France, Belgium, Netherlands, Luxemburg and North Africa and to the Republic of Ireland through ACCUSAY Diagnostics.
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Royal College Of Physicians Of Edinburgh
15 May, 2025
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
Online
21 May 2025
Online
9 June 2025
